Who backs Candid Therapeutics?
21 investors| Investor | Type |
|---|---|
| Fidelity Management & Research Company | Asset manager |
| Qiming Venture Partners | Venture capital |
| OrbiMed | Growth equity |
| Franklin Resources | — |
| Venrock | Venture capital |
| Foresite Capital | Venture capital |
| Samsara BioCapital | Venture capital |
| Redmile Group | PE / buyout |
| venBio | Venture capital |
| Soleus Capital | PE / buyout |
| + 11 more investors · a free account shows the complete list | |
The directory is free. Check sizes and activity — the working columns — are Pro.Unlock prospecting columns
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 21 names
- ·Watchlist + deal alerts for Candid Therapeutics
Create free account
No card required
For fundraisers
Work this list, don’t just read it
These 21 firms already write checks for companies like Candid Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.